Cytokinetics, Inc. (CYTK)

NASDAQ: CYTK · IEX Real-Time Price · USD
50.30
+0.83 (1.68%)
At close: Aug 12, 2022 4:00 PM
50.62
+0.32 (0.64%)
After-hours: Aug 12, 2022 6:10 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 2001
Revenue
70.4355.8326.8731.513.37106.4128.6646.9430.657.56
Upgrade
Revenue Growth (YoY)
26.15%107.79%-14.71%135.64%-87.44%271.30%-38.95%53.16%305.45%88.98%
Upgrade
Gross Profit
70.4355.8326.8731.513.37106.4128.6646.9430.657.56
Upgrade
Selling, General & Admin
96.852.8239.6131.2836.4727.8219.6717.2715.0912.43
Upgrade
Research & Development
159.9496.9586.1389.1490.359.946.444.4349.4535.64
Upgrade
Other Operating Expenses
000000000-0.06
Upgrade
Operating Expenses
256.74149.77125.74120.42126.7687.7266.0761.6964.5448.02
Upgrade
Operating Income
-186.31-93.94-98.87-88.92-113.418.69-37.41-14.75-33.89-40.46
Upgrade
Interest Expense / Income
16.4415.966.623.83.022.70.2700-0.09
Upgrade
Other Expense / Income
12.5617.3816.213.5811.38-0.46-0.17-0.11-0.180
Upgrade
Pretax Income
-215.31-127.29-121.69-106.29-127.7916.45-37.5-14.65-33.72-40.37
Upgrade
Net Income
-215.31-127.29-121.69-106.29-127.7916.45-37.5-14.65-33.72-40.37
Upgrade
Preferred Dividends
0000000001.31
Upgrade
Net Income Common
-215.31-127.29-121.69-106.29-127.7916.45-37.5-14.65-33.72-41.68
Upgrade
Shares Outstanding (Basic)
77655854494039362718
Upgrade
Shares Outstanding (Diluted)
77655854494339362718
Upgrade
Shares Change
19.16%12.07%5.80%10.15%16.08%9.65%8.70%30.92%50.63%53.45%
Upgrade
EPS (Basic)
-2.80-1.97-2.11-1.95-2.590.41-0.97-0.41-1.24-2.30
Upgrade
EPS (Diluted)
-2.80-1.97-2.11-1.95-2.590.39-0.97-0.41-1.24-2.30
Upgrade
Free Cash Flow Per Share
-2.49-0.03-1.62-1.88-2.120.890.11-1.29-0.30-1.85
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-264.50%-168.30%-368.00%-282.30%-848.30%17.60%-130.50%-31.40%-110.60%-535.20%
Upgrade
Profit Margin
-305.70%-228.00%-452.90%-337.40%-955.90%15.50%-130.90%-31.20%-110.00%-551.40%
Upgrade
Free Cash Flow Margin
-271.80%-3.80%-348.10%-324.10%-782.70%33.30%15.10%-97.90%-26.90%-444.00%
Upgrade
EBITDA
-196.6-109.5-113.78-101.25-122.8519.89-36.64-14.16-33.28-39.87
Upgrade
EBITDA Margin
-279.10%-196.10%-423.50%-321.40%-919.00%18.70%-127.90%-30.20%-108.60%-527.40%
Upgrade
Depreciation & Amortization
2.281.831.291.241.920.740.590.490.430.59
Upgrade
EBIT
-198.87-111.33-115.07-102.49-124.7719.15-37.23-14.65-33.72-40.46
Upgrade
EBIT Margin
-282.40%-199.40%-428.30%-325.40%-933.40%18.00%-129.90%-31.20%-110.00%-535.20%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).